Clinical trial
Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis
NCT00200655 · Nantes University Hospital, Other · Completed
Key facts
| NCT number | NCT00200655 |
|---|---|
| Title | Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis |
| Official title | Safety and Efficacy of Pravastatin in Relapsing-remitting MS: a Double Blind Placebo Controlled Study |
| Lead sponsor | Nantes University Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Relapsing-remitting Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Pravastatin, Placebo |
| Enrollment | 40 |
| Start date | Dec 1, 2004 |
| Completion | Nov 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 28, 2016 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: